Avidity Partners Management LP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 7:43 pm Sale | 2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 0 0.000% | -5,150,000 (Position Closed) | Filing |
| 2023-02-14 12:02 pm Purchase | 2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 5,150,000 9.000% | 2,127,210 (+70.37%) | Filing |
| 2022-02-01 3:33 pm Purchase | 2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 3,022,790 6.700% | 3,022,790 (New Position) | Filing |